Report - Pharmacotherapeutics of SARS-CoV-2 Infections...COVID-19 (Wang et al. 2020e). Favipiravir, an RNA poly-merase inhibitor previously used for the treatment of influen-za, is now being

Please pass captcha verification before submit form